Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Scott

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.
Neurology|December 17, 1998
Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazoleS J Read, T Hirano, D F Abbott, et al.
Annals of Neurology|August 12, 2000
The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic strokeS J Read, T Hirano, D F Abbott, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Gene Therapy|March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigenS Peinert, H M Prince, P M Guru, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2022
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0E Lopci, R J Hicks, A Dimitrakopoulou-Strauss, et al.
British Journal of Cancer|July 1, 2015
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancerA J Weickhardt, D S Williams, C K Lee, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
British Journal of Cancer|March 17, 2005
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFRC Panousis, V M Rayzman, T G Johns, et al.
Cancer Research|June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenograftsF T Lee, A Rigopoulos, C Hall, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.
Neurology|December 17, 1998
Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazoleS J Read, T Hirano, D F Abbott, et al.
Annals of Neurology|August 12, 2000
The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic strokeS J Read, T Hirano, D F Abbott, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Gene Therapy|March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigenS Peinert, H M Prince, P M Guru, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2022
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0E Lopci, R J Hicks, A Dimitrakopoulou-Strauss, et al.
British Journal of Cancer|July 1, 2015
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancerA J Weickhardt, D S Williams, C K Lee, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
British Journal of Cancer|March 17, 2005
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFRC Panousis, V M Rayzman, T G Johns, et al.
Cancer Research|June 5, 2001
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenograftsF T Lee, A Rigopoulos, C Hall, et al.
Pageof 17